Travoprost Ophthalmic Solution, 0.004% Solution/ Drops
Product Images NDC 0378-9651

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic Solution, 0.004% (NDC 0378-9651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of travoprost, the active ingredient in Travoprost Ophthalmic Solution, 0.004%. The diagram shows atoms and bonds representing the molecular structure of travoprost.*

FDA Label Image

Carton 2.5 mL (Image 02)

Packaging label for Travoprost Ophthalmic Solution, 0.004% (0.04 mg/mL), an ionic buffered ophthalmic solution by Mylan Pharmaceuticals Inc. The carton is primarily white with blue accents and includes NDC 0378-9651-32. It indicates a 2.5 mL Rx only product, with active ingredient travoprost and several inactives listed. The label cautions for use in the eyes only and lists storage conditions and usage instructions. The Mylan logo and website appear on the carton.*

FDA Label Image

Carton 5 mL (Image 03)

Packaging label for Travoprost Ophthalmic Solution, USP 0.004% (Ionic Buffered Solution) by Mylan Pharmaceuticals Inc. The label shows NDC 0378-9651-50, with a 5 mL bottle indicated. The label includes directions noting it is for use in the eyes only and lists active and inactive ingredients along with storage instructions and a warning that the package is not child resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.